Mark Daly | |
---|---|
Born | September 15, 1967 |
Citizenship | American |
Alma mater | Massachusetts Institute of Technology |
Known for | |
Awards | Curt Stern Award |
Scientific career | |
Institutions | Broad Institute of MIT and Harvard Massachusetts General Hospital Harvard University Institute for Molecular Medicine (FIMM) at the University of Helsinki |
Doctoral advisors | Eric Lander Gert-Jan van Ommen |
Mark Joseph Daly is Director of the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki,[1] a Professor of Genetics at Harvard Medical School, Chief of the Analytic and Translational Genetic Unit at Massachusetts General Hospital, and a member of the Broad Institute of MIT and Harvard.[2] In the early days of the Human Genome Project, Daly helped develop the genetic model by which linkage disequilibrium could be used to map the haplotype structure of the human genome.[3] In addition, he developed statistical methods to find associations between genes and disorders such as Crohn's disease,[4] inflammatory bowel disease, autism and schizophrenia.[5]
Daly is considered a pioneer in the field of human genetics, and is amongst the most cited scientists in the field,[5] and one of the top 100 most cited scientists of all time.[6] He was elected to the National Academy of Medicine in 2017.[7]